Chapman Steven Leonard sold $604K of NTRA
Chapman Steven Leonard (CEO AND PRESIDENT) sold 2,758 shares of Natera, Inc. (NTRA) at $219.08 ($0.60M total) on 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Insider transactions can move sentiment, but 10b5-1 pre-arranged sales are designed to reduce timing-based inference.
Market read
A routine 10b5-1 insider sale for NTRA; likely minimal incremental trading edge absent other catalysts.
What to watch
The sale size and remaining holdings matter; without context on prior sales cadence, the signal is hard to quantify.
Background
The article is an SEC EDGAR Form 4 disclosure of an officer/director transaction for Natera, Inc.
Ticker impact
Natera CEO and President Chapman Steven Leonard sold 2,758 shares in an open-market transaction disclosed on SEC Form 4.
Limited immediate price impact; any reaction is likely muted unless accompanied by unusual volume or other new company news.
The filing is a routine insider transaction with explicit 10b5-1 pre-arrangement, reducing interpretive value versus discretionary selling.
Market effects
No clear read-through to the broader biotech/diagnostics sector from a single 10b5-1 insider sale.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can still coincide with management’s private view of near-term risk.
Key entities
- issuerNatera, Inc.
Subject of the Form 4 insider transaction; CEO and President sold shares under a pre-arranged 10b5-1 plan.
- insiderChapman Steven Leonard
CEO and President who executed the open-market sale disclosed in the filing.
